Normal Eyes
13
1
1
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.7%
1 terminated out of 13 trials
91.7%
+5.1% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (13)
P200TE US Reference Database Study
High Resolution Imaging OCT Study
Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements
Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module
Agreement and Precision Study of UNITY® DX and a Comparator Biometer
The Heidelberg Engineering BI US Evaluation Study
Agreement and Precision Study
Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types
IMOvifa Perimeter Reference Database
The Heidelberg Engineering ANTERION Imaging Agreement Study
OCT Agreement and Precision Study
Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module
Appearance of Far Peripheral Retina in Normal Eyes by Ultra-widefield Fluorescein Angiography